View Author
patient c 1-inh study attack 1-inh virus treatment influenza activity inhibitor 1-inhibitor plaque level blood c 1-inhibitor angioedema response plasminogen atherosclerotic effect activator plasma pneumonia tissue t cells antigen protein c prophylactic t-cell protein factor netherland result pneumoniae range antithrombin c 1 inhibitor plasminogen activator inhibitor coagulation number anticoagulant c 4 levels product plaque-derived t cells antibody heparin pharmacokinetic pathway parameter sepsis atherosclerotic plaques prophylactic study fibrinolytic activation assay flammatory swets subs service tissue plasminogen activator saline lesion cetor responder culture conversion figure infection injury transplant ratio concentration blood t cells fibrinolysi tissue-type plasminogen activator control fibrinolytic activity prophylactic treatment thromb txb 2 transplant recipients 48 hrs